BioWorld

Dec. 7, 2015

FDA advisory committees on the decline, results vary

It's been three years since the FDA Safety and Innovation Act, the most recent reauthorization of the user fee program, was enacted, providing plenty of data on advisory committee meetings to examine. Read More

Week in review

Word on the street

Week in Washington

Public financing of biotechnology companies: Commenced trading in November 2015

Biotech money raised by month in 2015

Public financing of biotechnology companies: Filed and pending IPOs

2015 top private financings of public companies

Other financings of public biotechnology companies: November 2015

2015 top financings of private companies

Venture capital & other investments in private biotechnology companies: November 2015

Milestone payments from corporate partners: November 2015

Money raised by biotech in 2015 vs. 2014

Money raised by biotech: Jan. 1 - Dec. 3, 2015

Nasdaq Stock Index 2015

The week's biggest gainers and losers

BioWorld Stock Index 2015

BioWorld stock report for public biotechnology companies

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...